BIIB

NASDAQ · Biotechnology

Biogen Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$248.35

+4.42 (+1.81%)

As of Nov 7, 9:37 PM ET ·

Day Range $240.00 — $250.03

52W Range $148.51 — $258.78

Performance

1D —

1W -0.27%

1M +10.03%

3M +19.90%

6M +24.57%

1Y +58.93%

YTD +39.66%

Open$241.28

Previous Close$243.93

Day High$250.03

Day Low$240.00

52W High$258.78

52W Low$148.51

Volume—

Avg Volume1.33M

Market Cap36.60B

P/E Ratio43.85

EPS$5.65

SectorBiotechnology

Technical Indicators

Full analysis →

SMA 50 $230.01 Above

SMA 200 $203.18 Above

RSI (14) 60.2 Neutral

Trend Golden Cross Bullish

Analyst Ratings

Buy

44 analysts

32 Buy 11 Hold 1 Sell

Price Target -63.2% upside

Current
$248.35

Target
$91.45

$57.23 $91.45 avg $114.90

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	9.91B	10.00B	3.09B
Net Income	1.30B	1.18B	745.08M
Profit Margin	13.1%	12.4%	24.1%
EBITDA	2.23B	2.14B	1.15B
Free Cash Flow	—	—	775.19M
Rev Growth	-0.9%	-0.9%	+20.7%
Debt/Equity	0.34	0.34	1.02

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$291.31	+1.07%	49.3	509.50B
AMGN	Amgen Inc	$460.42	+0.03%	26.5	248.84B
GILD	Gilead Sciences Inc	$166.89	-0.41%	—	208.28B
VRTX	Vertex Pharmaceuticals Inc	$547.09	+0.85%	34.5	137.12B
REGN	Regeneron Pharmaceuticals	$904.35	+0.16%	19.4	93.39B
ALNY	Alnylam Pharmaceuticals Inc	$155.94	-0.46%	7.7	20.98B